• SENSEX
    NIFTY 50

CLSA maintains 'buy' rating for Sun Pharma

Updated : April 05, 2021 06:29:46 IST

The brokerage firm states that Teva Pharmaceutical had received US FDA approval for a generic version of Absorica
Absorica is one of Sun Pharma’s key products in its specialty portfolio
CLSA maintains 'buy' rating for Sun Pharma
Published : April 05, 2021 06:29 PM IST

You May Also Like

Live TV

recommended for you

Advertisement